[
    [
        {
            "time": "2020-11-09",
            "original_text": "人福医药再度转手“杰士邦” 安全套生意不好做了吗？公告精选：人福医药拟2亿美元转让乐福思集团40%股权，交易对方包括高瓴旗下基金。晚间重要公告2020年11月9日星期一。人福医药拟出售“杰士邦”母公司，高瓴资本斥2亿美元接手40%股权。安全套“老二”杰士邦再被卖身！高瓴接手，母公司负债200亿 偿债能力下降。人福医药拟出售乐福思集团40%股权 转让价格2亿美元 资产异常。人福医药：拟出售乐福思集团40%股权 资产异常。",
            "features": {
                "keywords": [
                    "人福医药",
                    "杰士邦",
                    "乐福思集团",
                    "高瓴资本",
                    "股权转让",
                    "负债",
                    "偿债能力"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药",
                    "消费品"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "人福医药再度转手“杰士邦” 安全套生意不好做了吗？公告精选：人福医药拟2亿美元转让乐福思集团40%股权，交易对方包括高瓴旗下基金。晚间重要公告2020年11月9日星期一。",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 3
            }
        }
    ]
]